Brief: Aker BioMarine Q4 Revenue Misses Analyst Expectations
15/02/2023 06:12
Feb 15 (Reuters) - Aker BioMarine Q4 revenue USD 79 million vs. estimate USD 85 million. * Q4 adjusted EBITDA USD 21 million
Recent news on Aker Biomarine ASA
See all newsBrief: Aker ASA: Conditions For Completion Of Merger With Aker Biomarine Satisfied
Brief: Aker Capital Buys 933,110 Aker BioMarine Shares
Brief: Aker Biomarine To Hold EGM On August 17
Brief: Aker Biomarine: Optional Cash Offer To Shareholders
Brief: Aker Biomarine: Proposed Merger And Optional Cash Offer